|
Dr. Weiden’s research career has focused on bridging psychopharmacology and public
health issues in the treatment of schizophrenia. He has published extensively on
the problem of medication nonadherence (noncompliance) with antipsychotic medications
among persons with schizophrenia.
Dr. Weiden recently joined the CCM faculty, having previously been Professor of
Psychiatry and Director of the Schizophrenia Research Service at SUNY Downstate
Medical Center in Brooklyn, New York. He completed his medical degree at SUNY at
Stony Brook in 1981, and his psychiatric residency at Payne Whitney Clinic–New York
Hospital in 1985. He also completed a psychiatric epidemiology fellowship at Mailman
School of Public Health at Columbia University in 1999.
Dr. Weiden’s career has focused on improving clinical outcomes for patients with
schizophrenia. He is known for his work on patient and family education addressing
treatment of psychosis. Dr. Weiden has received several awards from family and
patient advocacy groups and was named an Exemplary Psychiatrist on three separate
occasions by the National Alliance for the Mentally Ill (NAMI). Dr. Weiden’s book,
"Breakthroughs in Antipsychotic Medications: A Guide for Patients, Families, and Clinicians"
received the Ken Johnson Memorial Book Award in 2000 for one of the most outstanding
books in mental health. For his research on relapse prevention, Dr. Weiden received
NAMI’s Judith Silver Young Scientist Award in 1996.
Dr. Weiden’s research at CCM will focus on developing new pharmacologic and
psychosocial interventions to help address medication adherence problems for
patients with schizophrenia. One of the specific areas is the development of
Cognitive Behavioral interventions (CBT) for persons with psychotic disorders.
Research from the United Kingdom has shown that CBT-based interventions, when
used along with antipsychotic medication, can reduce persistent symptoms of
schizophrenia. Dr. Weiden has worked with leading CBT researchers from the UK
to develop and evaluate CBT interventions in the United States and has an active
research and training program in CBT. For more information on his research program
in CBT for psychosis, please follow this link:
http://www.medscape.com/viewarticle/558835 .
|